BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 3937834)

  • 1. Preliminary clinical trial of autologous bone marrow transplantation after in vitro monoclonal antibody and complement treatments in null cell-type acute lymphocytic leukemia.
    Morishima Y; Sao H; Ueda R; Morishita Y; Murase T; Kodera Y; Ohno R; Tahara T; Yoshikawa S; Kato Y
    Jpn J Cancer Res; 1985 Dec; 76(12):1222-9. PubMed ID: 3937834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological study for in vitro use of monoclonal antibody for autologous bone marrow transplantation in null cell-type acute lymphocytic leukemia.
    Sao H; Morishima Y; Ueda R; Yoshikawa S; Kodera Y; Ohno R; Takahashi T
    Jpn J Cancer Res; 1985 Dec; 76(12):1212-21. PubMed ID: 3937833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous bone marrow transplantation in acute lymphoblastic leukemia following in vitro treatment with monoclonal antibodies and with complement: analyses for two cases of failure.
    Ito T; Ishikawa Y; Noda M; Fujii R
    Jpn J Clin Oncol; 1987 Mar; 17(1):63-9. PubMed ID: 3031335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous BMT in high risk patients with CALLA-positive ALL: possible efficacy of ex vivo marrow leukemia cell purging with monoclonal antibodies and complement.
    Morishima Y; Miyamura K; Kojima S; Ueda R; Morishita Y; Sao H; Tanimoto M; Ohno R; Sobue R; Hirano M
    Bone Marrow Transplant; 1993 Apr; 11(4):255-9. PubMed ID: 7683550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement.
    Bast RC; Ritz J; Lipton JM; Feeney M; Sallan SE; Nathan DG; Schlossman SF
    Cancer Res; 1983 Mar; 43(3):1389-94. PubMed ID: 6337707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous bone marrow transplantation with marrow decontaminated by immunotoxin T 101 in the treatment of leukemia and lymphoma: first clinical observations.
    Gorin NC; Douay L; Laporte JP; Lopez M; Zittoun R; Rio B; David R; Stachowiak J; Jansen J; Cazellas P
    Cancer Treat Rep; 1985 Sep; 69(9):953-9. PubMed ID: 3896482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody purging and autologous bone marrow transplantation in acute myelogenous leukemia in complete remission.
    De Fabritiis P; Ferrero D; Sandrelli A; Tarella C; Meloni G; Pulsoni A; Pregno P; Badoni R; De Felice L; Gallo E
    Bone Marrow Transplant; 1989 Nov; 4(6):669-74. PubMed ID: 2819285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autotransplantation after in vitro immunotherapy of lymphoblastic leukemia.
    Wells JR; Billing R; Herzog P; Feig SA; Gale RP; Terasaki P; Cline MJ
    Exp Hematol; 1979; 7 Suppl 5():164-9. PubMed ID: 400684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
    Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC
    Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomagnetic purging procedure for autologous bone marrow transplantation in lymphoid malignancies.
    De Rosa L; Montuoro A; Pandolfi A; Lanti T; Pescador L; Morara R; De Laurenzi A
    Haematologica; 1991 Mar; 76 Suppl 1():37-40. PubMed ID: 1864552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
    Betticher DC; Huxol H; Müller R; Speck B; Nissen C
    Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purging leukemia remission marrows with alkyl-lysophospholipids, preclinical and clinical results.
    Vogler WR; Olson AC; Berdel WE; Okamoto S; Glasser L
    Prog Clin Biol Res; 1990; 333():1-18; discussion 19-20. PubMed ID: 2308973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro treatment of human acute lymphocytic leukemia cells in bone marrow with a cocktail of monoclonal antibodies.
    Nakamura H; Hirayama F; Tatsumi Y; Tani Y; Kubota Y; Kanakura Y; Oguma S; Ueda T; Shibata H; Masaoka T
    Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():537-42. PubMed ID: 6596454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-clinical evaluation of anti-lacto-N-fucopentaose III (CD15) monoclonal antibodies for ex vivo bone marrow purging in acute myeloid leukemia.
    Guyotat D; Shi ZH; Campos L; Rabat M; Bonnier S; Poncelet P; Laurent JC; Fiere D
    Bone Marrow Transplant; 1990 Dec; 6(6):385-90. PubMed ID: 1982926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous infusion of complement by an automated cell processor enhances cytotoxicity of monoclonal antibody sensitized leukemia cells.
    Howell AL; Fogg-Leach M; Davis BH; Ball ED
    Bone Marrow Transplant; 1989 May; 4(3):317-22. PubMed ID: 2659117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo effects of a monoclonal antibody-toxin conjugate for use in autologous bone marrow transplantation for patients with breast cancer.
    Coombes RC; Buckman R; Forrester JA; Shepherd V; O'Hare MJ; Vincent M; Powles TJ; Neville AM
    Cancer Res; 1986 Aug; 46(8):4217-20. PubMed ID: 3524802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective purging of bone marrow by a combination of immunorosette depletion and complement lysis.
    Slaper-Cortenbach IC; Admiraal LG; van Leeuwen EF; Kerr JM; von dem Borne AE; Tetteroo PA
    Exp Hematol; 1990 Jan; 18(1):49-54. PubMed ID: 2298269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination of small cell lung cancer cells in vitro from human bone marrow by a monoclonal antibody.
    Okabe T; Kaizu T; Ozawa K; Urabe A; Takaku F
    Cancer Res; 1985 May; 45(5):1930-3. PubMed ID: 2985239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-T cell immunotoxins containing pokeweed anti-viral protein: potential purging agents for human autologous bone marrow transplantation.
    Ramakrishnan S; Uckun FM; Houston LL
    J Immunol; 1985 Nov; 135(5):3616-22. PubMed ID: 3900212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies to carbohydrate antigens in autologous bone marrow transplantation.
    Ball ED; Howell AL
    J Cell Biochem; 1988 Apr; 36(4):445-52. PubMed ID: 3288649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.